Low Match Between the Emerging 'Mayotte-like' Strain and the 919-Strain Bovine Ephemeral Fever Vaccine.

IF 3.5 3区 医学 Q1 IMMUNOLOGY
Vaccines Pub Date : 2026-09-21 DOI:10.3390/vaccines14090830
Natalia Golender, Dan Gleser, Gabriel Kenigswald, Shani Scheinin, Eyal Klement
{"title":"Low Match Between the Emerging 'Mayotte-like' Strain and the 919-Strain Bovine Ephemeral Fever Vaccine.","authors":"Natalia Golender, Dan Gleser, Gabriel Kenigswald, Shani Scheinin, Eyal Klement","doi":"10.3390/vaccines14090830","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives</b>: Bovine ephemeral fever virus (BEFV) causes an economically important arthropod-borne cattle disease. In 2023, a lineage I \"Mayotte-like\" (ML) strain emerged in Israel during an outbreak in vaccinated herds, raising concerns about its antigenic match with the live-attenuated vaccine based on Australian strain 919. We compared G-protein neutralizing sites and cross-neutralization among the vaccine strain, Israeli lineage IIIa strains from 2000 and 2021, and ML. <b>Methods</b>: G1-G3 neutralizing-site sequences were compared. Serum-neutralization assays tested all four viruses using sera from 87 cattle across five vaccination/exposure groups. Log<sub>2</sub>-transformed titers were compared within animals. <b>Results</b>: ML differed from the vaccine strain at eight amino acid positions within G1-G3, whereas the lineage IIIa strains differed from the vaccine strain at three or four positions. In vaccinated, unexposed calves, neutralizing titers against the vaccine and 2021 strains were 4.0- and 2.7-fold higher, respectively, than against ML (both <i>p</i> < 0.01). In unvaccinated 2021-exposed cattle, titers against the 2021 strain were 6.5-fold higher than against ML (<i>p</i> < 0.01). In unvaccinated 2023-exposed cattle, titers against ML were 4.76-fold higher than against the vaccine strain (<i>p</i> < 0.01). Between-strain differences were smaller in vaccinated 2023-exposed cattle. <b>Conclusions:</b> Sequence divergence and cross-neutralization indicate a markedly reduced antigenic match between the Australian 919 vaccine strain and the ML strain. Given the continued circulation and emergence of antigenically divergent BEFV strains and their potential for geographic spread, challenge and field-effectiveness studies are urgently needed to determine the clinical protection afforded by the current vaccine. Lineage-matched or multivalent vaccines should therefore be prioritized to broaden protection against circulating and newly emerging strains.</p>","PeriodicalId":23634,"journal":{"name":"Vaccines","volume":"14 9","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13612049/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/vaccines14090830","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives: Bovine ephemeral fever virus (BEFV) causes an economically important arthropod-borne cattle disease. In 2023, a lineage I "Mayotte-like" (ML) strain emerged in Israel during an outbreak in vaccinated herds, raising concerns about its antigenic match with the live-attenuated vaccine based on Australian strain 919. We compared G-protein neutralizing sites and cross-neutralization among the vaccine strain, Israeli lineage IIIa strains from 2000 and 2021, and ML. Methods: G1-G3 neutralizing-site sequences were compared. Serum-neutralization assays tested all four viruses using sera from 87 cattle across five vaccination/exposure groups. Log2-transformed titers were compared within animals. Results: ML differed from the vaccine strain at eight amino acid positions within G1-G3, whereas the lineage IIIa strains differed from the vaccine strain at three or four positions. In vaccinated, unexposed calves, neutralizing titers against the vaccine and 2021 strains were 4.0- and 2.7-fold higher, respectively, than against ML (both p < 0.01). In unvaccinated 2021-exposed cattle, titers against the 2021 strain were 6.5-fold higher than against ML (p < 0.01). In unvaccinated 2023-exposed cattle, titers against ML were 4.76-fold higher than against the vaccine strain (p < 0.01). Between-strain differences were smaller in vaccinated 2023-exposed cattle. Conclusions: Sequence divergence and cross-neutralization indicate a markedly reduced antigenic match between the Australian 919 vaccine strain and the ML strain. Given the continued circulation and emergence of antigenically divergent BEFV strains and their potential for geographic spread, challenge and field-effectiveness studies are urgently needed to determine the clinical protection afforded by the current vaccine. Lineage-matched or multivalent vaccines should therefore be prioritized to broaden protection against circulating and newly emerging strains.

新出现的“马约特样”菌株与919株牛短暂热疫苗的低匹配度。
背景/目的:牛短暂热病毒(BEFV)是一种经济上重要的节肢动物传播的牛疾病。2023年,在以色列接种疫苗的畜群爆发期间,出现了一种谱系I“马约特样”(ML)菌株,引起了人们对其抗原与基于澳大利亚菌株919的减毒活疫苗匹配的担忧。我们比较了2000年和2021年接种的疫苗株、以色列IIIa株和ML株的g蛋白中和位点和交叉中和位点。方法:比较G1-G3中和位点序列。血清中和试验使用来自5个疫苗接种/暴露组87头牛的血清检测了所有4种病毒。在动物体内比较log2转化滴度。结果:ML与疫苗株在G1-G3中有8个氨基酸位置不同,而IIIa株与疫苗株在3或4个氨基酸位置不同。在未接种疫苗的小牛中,对疫苗和2021株的中和效价分别比对ML的中和效价高4.0倍和2.7倍(p < 0.01)。在未接种2021年暴露疫苗的牛中,2021菌株的滴度比ML高6.5倍(p < 0.01)。在未接种疫苗的2023暴露牛中,ML的滴度比疫苗株高4.76倍(p < 0.01)。在2023年接种过疫苗的牛株间差异较小。结论:序列差异和交叉中和表明澳大利亚919疫苗株与ML株的抗原匹配度明显降低。鉴于抗原性分化的BEFV毒株的持续传播和出现及其可能的地理传播,迫切需要进行挑战和实地有效性研究,以确定当前疫苗提供的临床保护。因此,应优先使用世系匹配或多价疫苗,以扩大对流行毒株和新出现毒株的保护。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Vaccines
Vaccines Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
8.90
自引率
16.70%
发文量
1853
审稿时长
18.06 days
期刊介绍: Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书